Durai Sundar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Machine Learning

Respiratory Syndrome Coronavirus

Chronic Myeloid Leukemia

Top Venues

Bioinformatics (Oxford, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Renu Wadhwa, Jia Wang, Seyad Shefrin, Huayue Zhang, Durai Sundar, Sunil C Kaul
Molecular Insights into the Anticancer Activity of Withaferin-A: The Inhibition of Survivin Signaling. Cancers 16 (17) (2024)
Swathik Clarancia Peter, Yogesh Kalakoti, Durai Sundar
Identifying High-Quality Leads among Screened Anticancerous Compounds Using SMILES Representations. ACS omega 9 (28) (2024)
Aditi Shenoy, Yogesh Kalakoti, Durai Sundar, Arne Elofsson
M-Ionic: prediction of metal-ion-binding sites from sequence using residue embeddings. Bioinformatics (Oxford, England) 40 (1) (2024)
Aditi Shenoy, Yogesh Kalakoti, Durai Sundar, Arne Elofsson
M-Ionic: prediction of metal-ion-binding sites from sequence using residue embeddings. Bioinformatics (Oxford, England) 40 (1) (2024)
Swathik Clarancia Peter, Yogesh Kalakoti, Durai Sundar
Identifying High-Quality Leads among Screened Anticancerous Compounds Using SMILES Representations. ACS omega 9 (28) (2024)
Aditi Shenoy, Yogesh Kalakoti, Durai Sundar, Arne Elofsson
M-Ionic: prediction of metal-ion-binding sites from sequence using residue embeddings. Bioinformatics (Oxford, England) 40 (1) (2024)
Pragya Kesarwani, Dhvani Sandip Vora, Durai Sundar
Improved Machine Learning-Based Model for the Classification of Off-Targets in the CRISPR/Cpf1 System. ACS omega 8 (48) (2023)
Dhvani Sandip Vora, Shashank Yadav, Durai Sundar
Hybrid Multitask Learning Reveals Sequence Features Driving Specificity in the CRISPR/Cas9 System. Biomolecules 13 (4) (2023)
Dhvani Sandip Vora, Shashank Yadav, Durai Sundar
Hybrid Multitask Learning Reveals Sequence Features Driving Specificity in the CRISPR/Cas9 System. Biomolecules 13 (4) (2023)
Dhvani Sandip Vora, Shashank Yadav, Durai Sundar
Hybrid Multitask Learning Reveals Sequence Features Driving Specificity in the CRISPR/Cas9 System. Biomolecules 13 (4) (2023)
Yogesh Kalakoti, Shashank Yadav, Durai Sundar
TransDTI: Transformer-Based Language Models for Estimating DTIs and Building a Drug Recommendation Workflow. ACS omega 7 (3) (2022)
Jyoti Sharma, Yogesh Kalakoti, Preeti Srivastava, Durai Sundar
Genome Sequence of a Potent Biosurfactant-Producing Bacterium, Franconibacter sp. Strain IITDAS19. Microbiology resource announcements 11 (8) (2022)
Navaneethan Radhakrishnan, Sunil C Kaul, Renu Wadhwa, Durai Sundar
Phosphatidylserine Exposed Lipid Bilayer Models for Understanding Cancer Cell Selectivity of Natural Compounds: A Molecular Dynamics Simulation Study. Membranes 12 (1) (2022)
Neha Quadir, Jasdeep Singh, Anwar Alam, Asrar Ahmad Malik, Syed Asad Rahman, Subhash Hira, Nasreen Zafar Ehtesham, Durai Sundar, Seyed Ehtesham Hasnain
Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges. Viruses 14 (12) (2022)
Neha Quadir, Jasdeep Singh, Anwar Alam, Asrar Ahmad Malik, Syed Asad Rahman, Subhash Hira, Nasreen Zafar Ehtesham, Durai Sundar, Seyed Ehtesham Hasnain
Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges. Viruses 14 (12) (2022)
Yogesh Kalakoti, Shashank Yadav, Durai Sundar
Deep Neural Network-Assisted Drug Recommendation Systems for Identifying Potential Drug-Target Interactions. ACS omega 7 (14) (2022)
Neha Quadir, Jasdeep Singh, Anwar Alam, Asrar Ahmad Malik, Syed Asad Rahman, Subhash Hira, Nasreen Zafar Ehtesham, Durai Sundar, Seyed Ehtesham Hasnain
Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges. Viruses 14 (12) (2022)
Neha Quadir, Jasdeep Singh, Anwar Alam, Asrar Ahmad Malik, Syed Asad Rahman, Subhash Hira, Nasreen Zafar Ehtesham, Durai Sundar, Seyed Ehtesham Hasnain
Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges. Viruses 14 (12) (2022)
Vidhi Malik, Navaneethan Radhakrishnan, Sunil C Kaul, Renu Wadhwa, Durai Sundar
Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone. Biomolecules 12 (2) (2022)
Neha Quadir, Jasdeep Singh, Anwar Alam, Asrar Ahmad Malik, Syed Asad Rahman, Subhash Hira, Nasreen Zafar Ehtesham, Durai Sundar, Seyed Ehtesham Hasnain
Evolution of SARS-CoV-2: BA.4/BA.5 Variants Continues to Pose New Challenges. Viruses 14 (12) (2022)
Anissa Nofita Sari, Jaspreet Kaur Dhanjal, Ahmed Elwakeel, Vipul Kumar, Hazna Noor Meidinna, Huayue Zhang, Yoshiyuki Ishida, Keiji Terao, Durai Sundar, Sunil C Kaul, Renu Wadhwa
A Low Dose Combination of Withaferin A and Caffeic Acid Phenethyl Ester Possesses Anti-Metastatic Potential In Vitro: Molecular Targets and Mechanisms. Cancers 14 (3) (2022)
Dhvani Sandip Vora, Yugesh Verma, Durai Sundar
A Machine Learning Approach to Identify the Importance of Novel Features for CRISPR/Cas9 Activity Prediction. Biomolecules 12 (8) (2022)
Vipul Kumar, Anissa Nofita Sari, Hazna Noor Meidinna, Jaspreet Kaur Dhanjal, Chandru Subramani, Brohmomoy Basu, Sunil C Kaul, Sudhanshu Vrati, Durai Sundar, Renu Wadhwa
Computational and in vitro experimental analyses of the anti-COVID-19 potential of Mortaparib and MortaparibPlus. Bioscience reports 41 (10) (2021)